Semaglutide vs Saxenda: Which Weight Loss Drug Is Better in the UK?
By Dr. Emma Richardson
Trying to lose weight can feel like an uphill battle, especially when options seem overwhelming. If you’ve been researching weight loss medications in the UK, you’ve likely come across two popular injectable treatments: Semaglutide and Saxenda. Both have shown promising results, but which one is the better choice for you? Let’s dive into the differences, benefits, and considerations—so you can make an informed decision.
Understanding Semaglutide and Saxenda
What is Semaglutide?
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed to treat Type 2 diabetes. However, clinical trials have shown it to be highly effective for weight loss, even in people without diabetes. It works by mimicking a hormone that regulates appetite and food intake, helping you feel full and eat less. Semaglutide is often prescribed under brand names like Wegovy, specifically for weight management.
What is Saxenda?
Saxenda, the brand name for liraglutide at a higher dose, is also a GLP-1 receptor agonist. Approved by the NHS for weight management, Saxenda helps reduce hunger and control appetite. It’s injected daily and has been used widely in the UK for obesity treatment.
Effectiveness: Which One Helps You Lose More Weight?
Effectiveness is arguably the most important factor. Let’s look at what the research and clinical trials say.
- Semaglutide: Clinical studies have shown average weight loss of 15% or more of body weight over 68 weeks with Semaglutide 2.4 mg weekly injections (STEP 1 trial, NEJM).
- Saxenda: Studies report around 8-10% body weight reduction after 56 weeks of daily injections (SCALE study, The Lancet Diabetes & Endocrinology).
Comparison Table: Semaglutide vs Saxenda
| Feature | Semaglutide | Saxenda |
|---|---|---|
| Active Ingredient | Semaglutide | Liraglutide |
| Administration | Once weekly injection | Once daily injection |
| Typical Weight Loss | ~15% body weight over 68 weeks | 8-10% body weight over 56 weeks |
| Side Effects | Nausea, vomiting, constipation (usually mild) | Nausea, vomiting, diarrhoea, constipation |
| Cost in the UK | Generally higher; varies by provider | Moderate; widely available |
| Approval Status | Approved by MHRA and NICE for obesity under specific criteria | Approved by MHRA and NHS for obesity treatment |
Side Effects & Safety Considerations
Both drugs share similar side effects, predominantly related to digestive discomfort such as nausea and mild gastrointestinal upset. These usually improve after the first few weeks. It’s important to discuss your full medical history with your healthcare professional before starting either medication.
Neither Semaglutide nor Saxenda is suitable if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (FDA Warning).
Cost & Accessibility In the UK
The cost can be a significant deciding factor. Saxenda is generally more accessible through private clinics in the UK, with prices varying around £200-£300 per month. Semaglutide for weight loss, branded as Wegovy in some countries, is still becoming more widely available in the UK but may come at a higher cost through private prescription services. The NHS currently offers GLP-1 medications mainly for diabetes but increasingly supports obesity treatment in select cases (NICE guidelines).
My Personal Take: Which One Would I Choose?
Having worked closely with patients struggling with weight management, I find Semaglutide’s once-weekly dosing and greater average weight loss compelling. The convenience of fewer injections is a big plus for many. That said, Saxenda is a proven, effective option with a longer track record in the UK.
Ultimately, the “better” drug depends on your lifestyle, medical history, and budget. I always recommend consulting a healthcare professional who can provide personalised advice and monitoring throughout your weight loss journey.
Ready to Take the Next Step?
If you’re interested in exploring Semaglutide for weight loss, check out trusted UK providers where you can order Semaglutide safely online with professional guidance.
Or, if Saxenda sounds like a better fit, you can find reliable UK clinics offering Saxenda consultation and prescriptions here.
Frequently Asked Questions
- Is Semaglutide available on the NHS for weight loss?
- Currently, Semaglutide is not widely prescribed for obesity on the NHS but may be available through certain clinical trials or specialised services.
- Can I take Semaglutide and Saxenda together?
- No, they are both GLP-1 agonists and should not be combined. Your doctor will recommend one based on your needs.
- How soon will I see results?
- Many patients notice appetite reduction within the first few weeks; weight loss typically becomes more noticeable after 2-3 months.
- Do I need to follow a special diet?
- While these medications help reduce appetite, combining treatment with a balanced diet and exercise enhances success.
- Are there weight regain risks after stopping?
- Weight regain can occur if lifestyle changes aren’t maintained. Medical supervision is recommended when stopping treatment.
Final Thoughts
Both Semaglutide and Saxenda offer powerful tools in the fight against obesity, each with unique pros and cons. Semaglutide’s once-weekly dose and superior weight loss statistics make it a very attractive option, but Saxenda’s established safety profile and accessibility in the UK still make it a go-to for many.
If you’re ready to explore your options, start your Semaglutide journey here or find out more about Saxenda today. Remember, the best choice is the one tailored to your unique health needs and lifestyle.